Sign in

CIK 0001604464

  • Non-accelerated filer
  • Smaller reporting company

Atara Biotherapeutics, Inc.

Sign in to watch
Ticker
ATRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460920988
Phone
+1 805-623-4211
Business address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
Open-market buys, last 90 days
$999,994
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$999,994. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Cherry Brian N +$1000K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-05-15 Soffer Gad EVP & Chief Strategy Officer Shares withheld for taxes −382 $45.90 $18K 266,506
2018-05-15 Clark Mitchall G. EVP & Chief R & QA Officer Option exercise +4,808 138,479
2018-05-15 Clark Mitchall G. EVP & Chief R & QA Officer Option exercise · Restricted Stock Units −4,808 0
2018-05-15 Gallagher Carol Giltner Director Option exercise +545 111,465
2018-05-15 Gallagher Carol Giltner Director Option exercise · Restricted Stock Units −545 0
2018-05-15 Haqq Christopher EVP, R&D & Chief Scientific Of Option exercise +25,000 $11.00 $275K 357,905
2018-05-15 Haqq Christopher EVP, R&D & Chief Scientific Of Sale −6,885 $44.44 $306K 351,020
2018-05-15 Haqq Christopher EVP, R&D & Chief Scientific Of Sale −9,638 $45.21 $436K 341,382
2018-05-15 Haqq Christopher EVP, R&D & Chief Scientific Of Sale −9,252 $46.02 $426K 332,130
2018-05-15 Haqq Christopher EVP, R&D & Chief Scientific Of Option exercise · Employee Stock Option (Right to Buy) −25,000 25,000
2018-05-14 Fust Matthew K Director Sale −12,286 $43.57 $535K 19,820
2018-05-10 Ciechanover Isaac E. Chief Executive Officer Sale −2,200 $40.08 $88K 182,278
2018-05-10 Ciechanover Isaac E. Chief Executive Officer Sale −2,200 $40.98 $90K 180,078
2018-05-09 Ciechanover Isaac E. Chief Executive Officer Sale −1,300 $38.35 $50K 187,578
2018-05-09 Ciechanover Isaac E. Chief Executive Officer Sale −3,100 $39.50 $122K 184,478
2018-05-08 Porter Derrell SVP, Head of Global Commercial Sale −1,544 $40.15 $62K 12,500
2018-05-07 Berger Dietmar Global Head of R&D Grant or award +50,000 50,000
2018-05-07 Berger Dietmar Global Head of R&D Grant or award · Employee Stock Option (Right to Buy) +85,000 85,000
2018-04-27 Ciechanover Isaac E. Chief Executive Officer Sale −3,900 $42.63 $166K 189,378
2018-04-27 Ciechanover Isaac E. Chief Executive Officer Sale −500 $43.95 $22K 188,878

Page 31 of 44 · 867 trades